Assessment of Optimal Egg Intake in a Healthy Population

University of Connecticut

Status: Completed

Conditions: Cardiovascular Disease

Treatments: Other: Eggs

Study type: Interventional

Funder types: Other

Identifiers

NCT02531958

H15-227

Details and patient eligibility

About

Recently, the United States Department of Agriculture (USDA) has recommended removal of the 300mg/day limit on dietary cholesterol intake due to a lack of evidence supporting a connection between cholesterol intake and increased risk for cardiovascular disease (CVD). Previous work has shown that daily intake of eggs actually favorably alters many parameters associated with CVD risk. Conversely, emerging research suggests that choline, a nutrient in eggs, may be converted into trimethylamine oxide (TMAO) by the intestinal microbiota. TMAO is thought to increase the risk for CVD. Therefore, the purpose of this study is to determine a threshold of daily egg intake at which the risk for CVD is not negatively impacted in a young, healthy population.

Full description

The purpose of this study is to establish a threshold of egg intake at which CVD risk is not negatively altered in young, healthy individuals. Participants (age 18-30, healthy lipid profile) will undergo a 2-week washout period followed by daily intake of 1, 2, and 3 eggs per day for 4 weeks each. Blood samples will be collected at baseline and following each 4-week dietary period. Samples will be analyzed to determine the impact of daily intake of increasing numbers of eggs on blood lipids, TMAO, biomarkers of oxidative stress and inflammation, and expression of cholesterol-related genes.

Enrollment: 38 patients

Sex: All

Ages: 18 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• BMI 18.5-29.9 kg/m2
• Proficient in English
• Cholesterol ≤ 240 mg/dL
• Willing to consume 1, 2, and 3 eggs per day for 4 weeks each

Exclusion criteria

• Diabetes mellitus, cardiovascular disease, history of stroke, renal disease, liver disease, cancer, or eating disorder
• Taking glucose-lowering supplements or medications
• Taking triglyceride-lowering medications, bile acid sequestrants, or high-dose chromium or cinnamon supplements
• Plasma glucose < 126 mg/dL, triglycerides > 500 mg/dL, or blood pressure > 140/90 mmHg (average of 3 readings)
• Allergy to eggs

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

38 participants in 3 patient groups

1 Egg

Experimental group

Description:

Consumption of 1 egg per day for 4 weeks

Treatment:

Other: Eggs

2 Eggs

Experimental group

Description:

Consumption of 2 eggs per day for 4 weeks

Treatment:

Other: Eggs

3 Eggs

Experimental group

Description:

Consumption of 3 eggs per day for 4 weeks

Treatment:

Other: Eggs